Kadriye Akpinar
Research Subjects
Kadriye Akpinar has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alev Lazoğlu Özkaya
Department of Biochemistry, Erzurum Regional Training and Research Hospital, Erzurum 25050, Türkiye
1 shared publication Diler Aslan
Pamukkale University, Turkey
1 shared publication- Diler Aslan
Department of Medical Biochemistry , School of Medicine, Pamukkale University , Denizli , Turkey
1 shared publication - Efe Emre Kaşikçi
UNIVERSITY OF HEALTH SCIENCES, İZMİR DR. SUAT SEREN HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY
1 shared publication - Esin Avci
Department of Medical Biochemistry, Pamukkale University School of Medicine, Denizli, Turkey
1 shared publication - Hande Şenol
Department of Biostatistics, Pamukkale University School of Medicine, Denizli, Turkey
1 shared publication
Latest Publications
- Open Access
- 10 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (41) , e45111
Association between pulmonary function tests and lipid levels
This study aimed to investigate the association between pulmonary function tests (PFTs) and biochemical parameters, including lipid levels, monocyte-to-high-density lipoprotein (HDL) ratio (MHR), glucose, and glycated hemoglobin (HbA1c), undergoing routine health checkups. Cholesterol, low-density lipoprotein cholesterol, HDL cholesterol, triglyceride (TG), and glucose levels of a total of 153 subjects (51% male) were analyzed using the Abbott Architect c8000 auto-analyzer. HbA1c was measured using the Lifotronic H9 HPLC system. Monocyte count was determined using the Abbott CELL-DYN Ruby fully automated blood counter. PFTs were conducted using a spirometer, and data were analyzed using SPSS version 27.0. Glucose, cholesterol, low-density lipoprotein cholesterol, HDL cholesterol, TG, and HbA1c levels were significantly higher in the overweight and obese group than in the control group ( P < .05). Similarly, glucose, cholesterol, TG, and HbA1c levels were significantly higher in the diabetic and prediabetic groups compared to the control group ( P < .05). The high lipid group exhibited elevated monocyte counts and MHR, along with reduced HDL levels compared to the optimal lipid group. Smokers had a significantly higher MHR in smokers (0.012) than nonsmokers (0.010), and males (0.013) exhibited higher MHR values than females (0.008). Significant differences in PFTs were observed for smokers, who exhibited lower forced vital capacity (FVC) (3.70 ± 0.99 L) and forced expiratory volume in 1 second (FEV1) (3.05 ± 0.77 L/s) compared to nonsmokers (FVC: 4.23 ± 1.16 L and FEV1: 3.44 ± 0.84 L/s). Similarly, females had lower FVC (3.14 ± 0.59 L), FEV1 (3.05 ± 0.77 L/s), and peak expiratory flow (5.1 ± 1.16 L/s) compared to males (FVC: 4.23 ± 1.16 L, FEV1: 3.44 ± 0.84 L/s, peak expiratory flow: 7.3 ± 1.89 L/s). In the multivariable regression model, the associations of lipids, body mass index, and smoking were not independently significant, whereas age and sex emerged as the strongest factors associated with pulmonary function. Older age was linked to significant declines in FVC and FEV1, and males exhibited significantly higher lung volumes than females. In conclusion, age and sex are significantly associated with pulmonary function, while the associations of smoking, body mass index, HbA1c, and lipid levels appear to be more complex and require further investigation.
- 10 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (41) , e45111
Open AccessAssociation between pulmonary function tests and lipid levels
This study aimed to investigate the association between pulmonary function tests (PFTs) and biochemical parameters, including lipid levels, monocyte-to-high-density lipoprotein (HDL) ratio (MHR), glucose, and glycated hemoglobin (HbA1c), undergoing routine health checkups. Cholesterol, low-density lipoprotein cholesterol, HDL cholesterol, triglyceride (TG), and glucose levels of a total of 153 subjects (51% male) were analyzed using the Abbott Architect c8000 auto-analyzer. HbA1c was measured using the Lifotronic H9 HPLC system. Monocyte count was determined using the Abbott CELL-DYN Ruby fully automated blood counter. PFTs were conducted using a spirometer, and data were analyzed using SPSS version 27.0. Glucose, cholesterol, low-density lipoprotein cholesterol, HDL cholesterol, TG, and HbA1c levels were significantly higher in the overweight and obese group than in the control group ( P < .05). Similarly, glucose, cholesterol, TG, and HbA1c levels were significantly higher in the diabetic and prediabetic groups compared to the control group ( P < .05). The high lipid group exhibited elevated monocyte counts and MHR, along with reduced HDL levels compared to the optimal lipid group. Smokers had a significantly higher MHR in smokers (0.012) than nonsmokers (0.010), and males (0.013) exhibited higher MHR values than females (0.008). Significant differences in PFTs were observed for smokers, who exhibited lower forced vital capacity (FVC) (3.70 ± 0.99 L) and forced expiratory volume in 1 second (FEV1) (3.05 ± 0.77 L/s) compared to nonsmokers (FVC: 4.23 ± 1.16 L and FEV1: 3.44 ± 0.84 L/s). Similarly, females had lower FVC (3.14 ± 0.59 L), FEV1 (3.05 ± 0.77 L/s), and peak expiratory flow (5.1 ± 1.16 L/s) compared to males (FVC: 4.23 ± 1.16 L, FEV1: 3.44 ± 0.84 L/s, peak expiratory flow: 7.3 ± 1.89 L/s). In the multivariable regression model, the associations of lipids, body mass index, and smoking were not independently significant, whereas age and sex emerged as the strongest factors associated with pulmonary function. Older age was linked to significant declines in FVC and FEV1, and males exhibited significantly higher lung volumes than females. In conclusion, age and sex are significantly associated with pulmonary function, while the associations of smoking, body mass index, HbA1c, and lipid levels appear to be more complex and require further investigation.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Comparison of Urine Drug Abuse Testing Analyzed in Glass and Plastic Tubes
Kullanımının tespiti amacıyla kullanılmaktadır. Biz bu çalışmada idrarda madde analizinde ucuz ve pratik olan plastik tüplerin cam tüplere alternatif olup olamayacağını araştırmayı amaçladık. Gereç ve Yöntem: 80 yetişkin gönüllüden alınan taze idrar örnekleri cam ve plastik tüplere aktarıldı ve örneklerde idrar bütünlük testleri çalışılarak örneklerin uygunlukları değerlendirildi. Ardından idrarda amfetaminler (AMP), benzodiazepinler (BNZ), kokain (COC), opiatlar (OPI) ve kannabinoidlerin (THC) düzeyi Roche Cobas c 501’de immünoanaliz yöntemiyle yarı kantitatif olarak ölçüldü. Testin pozitifliği için kesim değerleri; AMP> 500μg/L, BNZ> 300μg/L, COC> 150μg/L, OPI> 2000μg/L ve THC> 50μg/L olarak alındı. İdrar örneklerinin bekletilmesinin test sonucuna etkisini araştırmak için, numunelerden 32 tanesi herhangi bir koruyucu madde olmadan dört saat bekletildi ve tekrar analiz edildi. Verilerin analizinde SPSS 25.0 programı kullanıldı. Bulgular: AMP, BNZ, COC, OPI ve THC konsantrasyonlarında cam ve plastik tüpler arasında anlamlı bir fark yoktu. OPI açısından istatistiksel olarak anlamlı fark bulundu (p= 0.005) ancak OPI düzeylerindeki değişiklik klinik kararı (pozitiflik) değiştirmedi. Her iki tüpte de aynı analit ölçümüne ilişkin tüm sonuçlar arasında anlamlı yüksek korelasyon vardı (p= 0.0001). Bekletilen idrar numunelerinde (n= 32) sadece BNZ plastik tüpte istatistiksel olarak anlamlı yüksek bulundu (p= 0.037); ancak bu farklılıklar örneklerin pozitifliğini veya negatifliğini değiştirmedi ve klinik olarak anlamsızdı. Tüm testler için tüp türleri ve süre açısından örnekler karşılaştırıldığında anlamlı korelasyonlar mevcuttu (p <0.001). Sonuç: Bu çalışmanın sonucunda, kötüye kullanılan ilaçların analizinde cam tüpler yerine plastik tüplerin kullanılabileceği, oda sıcaklığında dört saat saklandıktan sonra madde konsantrasyonlarında anlamlı bir değişimin olmadığı sonucu çıkarılabilir.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Comparison of Urine Drug Abuse Testing Analyzed in Glass and Plastic Tubes
Kullanımının tespiti amacıyla kullanılmaktadır. Biz bu çalışmada idrarda madde analizinde ucuz ve pratik olan plastik tüplerin cam tüplere alternatif olup olamayacağını araştırmayı amaçladık. Gereç ve Yöntem: 80 yetişkin gönüllüden alınan taze idrar örnekleri cam ve plastik tüplere aktarıldı ve örneklerde idrar bütünlük testleri çalışılarak örneklerin uygunlukları değerlendirildi. Ardından idrarda amfetaminler (AMP), benzodiazepinler (BNZ), kokain (COC), opiatlar (OPI) ve kannabinoidlerin (THC) düzeyi Roche Cobas c 501’de immünoanaliz yöntemiyle yarı kantitatif olarak ölçüldü. Testin pozitifliği için kesim değerleri; AMP> 500μg/L, BNZ> 300μg/L, COC> 150μg/L, OPI> 2000μg/L ve THC> 50μg/L olarak alındı. İdrar örneklerinin bekletilmesinin test sonucuna etkisini araştırmak için, numunelerden 32 tanesi herhangi bir koruyucu madde olmadan dört saat bekletildi ve tekrar analiz edildi. Verilerin analizinde SPSS 25.0 programı kullanıldı. Bulgular: AMP, BNZ, COC, OPI ve THC konsantrasyonlarında cam ve plastik tüpler arasında anlamlı bir fark yoktu. OPI açısından istatistiksel olarak anlamlı fark bulundu (p= 0.005) ancak OPI düzeylerindeki değişiklik klinik kararı (pozitiflik) değiştirmedi. Her iki tüpte de aynı analit ölçümüne ilişkin tüm sonuçlar arasında anlamlı yüksek korelasyon vardı (p= 0.0001). Bekletilen idrar numunelerinde (n= 32) sadece BNZ plastik tüpte istatistiksel olarak anlamlı yüksek bulundu (p= 0.037); ancak bu farklılıklar örneklerin pozitifliğini veya negatifliğini değiştirmedi ve klinik olarak anlamsızdı. Tüm testler için tüp türleri ve süre açısından örnekler karşılaştırıldığında anlamlı korelasyonlar mevcuttu (p <0.001). Sonuç: Bu çalışmanın sonucunda, kötüye kullanılan ilaçların analizinde cam tüpler yerine plastik tüplerin kullanılabileceği, oda sıcaklığında dört saat saklandıktan sonra madde konsantrasyonlarında anlamlı bir değişimin olmadığı sonucu çıkarılabilir.
- 1 January 2024
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 70 (03/2024) , 533-541
Evaluation of the Urine Drug Abuse Screening Tests
Background: Substance use is an important public health problem and increasing all over the world. Different methods have been defined for drug abuse testing in medical laboratories. We aimed to compare two urine drug screening methods with liquid chromatography -tandem mass spectrometry (LCMS/MS). Methods: A total of 102 patients' urine samples were analyzed by test dip card and EMIT (enzyme multiplied immunoassay technique). Randomly selected samples (n = 51; 50%) were also analyzed by LCMS/MS as the reference method. Results: The drug results of all patients analyzed with the test card and EMIT were compatible. Nine of 51 samples (18%) were negative according to all methods. The sensitivity and specificity percentages of AMP, COC, MDMA, OPI/MOP, and THC using test card were 70/96, 100/100, 47/100, 50/100, and 80/85, respectively. Similarly, the sensitivity and specificity percentages of AMP, COC, MDMA, OPI/MOP, and THC using EMIT were 76/97, 100/100, 57/100, 56/100, and 76/91, respectively. Conclusions: The performances of two immunochemical methods were similar for AMP, BZO, COC, MDMA, OPI/MOP, and THC whereas lower than LCMS/MS for AMP, MDMA, OPI/MOP, and THC. A sample that is positive according to any immunochemical method should be confirmed by definitive techniques such as LCMS/MS. (Clin. Lab. 2024;70:533-541. DOI: 10.7754/Clin.Lab.2023.230812)
- 1 January 2024
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 70 (03/2024) , 533-541
Evaluation of the Urine Drug Abuse Screening Tests
Background: Substance use is an important public health problem and increasing all over the world. Different methods have been defined for drug abuse testing in medical laboratories. We aimed to compare two urine drug screening methods with liquid chromatography -tandem mass spectrometry (LCMS/MS). Methods: A total of 102 patients' urine samples were analyzed by test dip card and EMIT (enzyme multiplied immunoassay technique). Randomly selected samples (n = 51; 50%) were also analyzed by LCMS/MS as the reference method. Results: The drug results of all patients analyzed with the test card and EMIT were compatible. Nine of 51 samples (18%) were negative according to all methods. The sensitivity and specificity percentages of AMP, COC, MDMA, OPI/MOP, and THC using test card were 70/96, 100/100, 47/100, 50/100, and 80/85, respectively. Similarly, the sensitivity and specificity percentages of AMP, COC, MDMA, OPI/MOP, and THC using EMIT were 76/97, 100/100, 57/100, 56/100, and 76/91, respectively. Conclusions: The performances of two immunochemical methods were similar for AMP, BZO, COC, MDMA, OPI/MOP, and THC whereas lower than LCMS/MS for AMP, MDMA, OPI/MOP, and THC. A sample that is positive according to any immunochemical method should be confirmed by definitive techniques such as LCMS/MS. (Clin. Lab. 2024;70:533-541. DOI: 10.7754/Clin.Lab.2023.230812)
- Open Access
- 20 September 2023
- Published by Pamukkale University in Pamukkale Medical Journal
ÜLSERATİF KOLİTLİ HASTALARDA SERUM HEPSİDİN DÜZEYİ ÖLÇÜMÜNÜN HASTALIK AKTİVASYONUNU DEĞERLENDİRMEDEKİ ETKİNLİĞİ VE GÜVENİRLİĞİ
Adı soyadı: Efe Emre KAŞIKÇI Doğum tarihi: 24.01.1989 Yabancı dil bilgisi: İngilizce Görev yeri: Suat Seren Göğüs Hastalıkalrı Hastanesi- İç Hastalıkları / Alerji ve Klinik İmmünoloji Bilim Dalı E-posta adresi: efemre@gmail.com Telefon: 05077926171 EĞİTİM BİLGİLERİ Tıp Fakültesi Selçuk Üniversitesi Tıp Fakültesi 2008-20014 İç Hastalıkları Pamukkale Tıp Fakültesi 2015-2019 Alerji İmmünoloji Suat Seren Göğüüs Hastalıkları SBÜ 2020-
- 20 September 2023
- Published by Pamukkale University in Pamukkale Medical Journal
Open AccessÜLSERATİF KOLİTLİ HASTALARDA SERUM HEPSİDİN DÜZEYİ ÖLÇÜMÜNÜN HASTALIK AKTİVASYONUNU DEĞERLENDİRMEDEKİ ETKİNLİĞİ VE GÜVENİRLİĞİ
Adı soyadı: Efe Emre KAŞIKÇI Doğum tarihi: 24.01.1989 Yabancı dil bilgisi: İngilizce Görev yeri: Suat Seren Göğüs Hastalıkalrı Hastanesi- İç Hastalıkları / Alerji ve Klinik İmmünoloji Bilim Dalı E-posta adresi: efemre@gmail.com Telefon: 05077926171 EĞİTİM BİLGİLERİ Tıp Fakültesi Selçuk Üniversitesi Tıp Fakültesi 2008-20014 İç Hastalıkları Pamukkale Tıp Fakültesi 2015-2019 Alerji İmmünoloji Suat Seren Göğüüs Hastalıkları SBÜ 2020-
- 18 August 2022
- Published by Walter de Gruyter GmbH in Diagnosis
- Vol. 9 (4) , 499-507
miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy
Objectives: Microribonucleic acids (microRNA/miRNA/miR-) are predicted to be useful in the early diagnosis, monitoring, and treatment of diabetic nephropathy (DN). We aimed to investigate the relationship of DN to miR-21-3p, miR-29a-3p, miR-29b-3p, miR-29c-3p, miR-126-3p, miR-129-1-3p, miR-137, miR-192-5p, miR-212-3p, and miR-320c. Methods: There were 50 healthy controls and 100 patients with type 2 diabetes mellitus (T2DM). The diabetic patients were divided into three subgroups: normal to mildly increased (A1, n=51), moderately increased (A2, n=25), and severely increased (A3, n=24) albuminuria. The biochemical measurements were analysed using Roche Cobas 8000. The plasma miRNAs were analysed using RT-qPCR based on SYBR green chemistry. Results: The relative expression of miR-21-3p was significantly lower in the (A3 p=0.005, 6.6-fold decrease) and DN (A1 + A3) (p=0.005, 6.6-fold decrease) groups compared to the controls. The relative expression of miR-192-5p was also significantly lower in the DN group (p=0.027, 2.4-fold decrease) compared to the controls. The area under curve value was 0.726 for miR-21-3p and 0.717 for miR-192-5p for distinguishing the DN group from the controls. Conclusions: The decreased expressions of miR-21-3p and miR-192-5p are associated with the development of DN and may be potential biomarkers for the early diagnosis of DN.
- 18 August 2022
- Published by Walter de Gruyter GmbH in Diagnosis
- Vol. 9 (4) , 499-507
miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy
Objectives: Microribonucleic acids (microRNA/miRNA/miR-) are predicted to be useful in the early diagnosis, monitoring, and treatment of diabetic nephropathy (DN). We aimed to investigate the relationship of DN to miR-21-3p, miR-29a-3p, miR-29b-3p, miR-29c-3p, miR-126-3p, miR-129-1-3p, miR-137, miR-192-5p, miR-212-3p, and miR-320c. Methods: There were 50 healthy controls and 100 patients with type 2 diabetes mellitus (T2DM). The diabetic patients were divided into three subgroups: normal to mildly increased (A1, n=51), moderately increased (A2, n=25), and severely increased (A3, n=24) albuminuria. The biochemical measurements were analysed using Roche Cobas 8000. The plasma miRNAs were analysed using RT-qPCR based on SYBR green chemistry. Results: The relative expression of miR-21-3p was significantly lower in the (A3 p=0.005, 6.6-fold decrease) and DN (A1 + A3) (p=0.005, 6.6-fold decrease) groups compared to the controls. The relative expression of miR-192-5p was also significantly lower in the DN group (p=0.027, 2.4-fold decrease) compared to the controls. The area under curve value was 0.726 for miR-21-3p and 0.717 for miR-192-5p for distinguishing the DN group from the controls. Conclusions: The decreased expressions of miR-21-3p and miR-192-5p are associated with the development of DN and may be potential biomarkers for the early diagnosis of DN.
- Open Access
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 43 (3) , 340-348
Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
Introduction: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). Methods: Study group included 52 controls (46% male, age: 54.5±12.4) and 101 diabetic patients (46.5% male, age: 58.2±11). The diabetics were divided into three subgroups according to 24-hour urine albumin: normal to mildly increased (A1) (n=51), moderately increased (A2) (n=25), severely increased (A3) (n=25) albuminuria. Creatinine clearance (CrCl) was determined. Correlations between CrCl and eGFRs estimated according to the CKD-EPI, MDRD, and Cockcroft-Gault (CG) formulas, and ROC curves were evaluated. Data were analyzed using SPSS 22.0. Results: Only CKD-EPI-cys eGFR was significantly lower in the A1 group than the controls (p=0.021). All GFRs were lower in the A3 group than the control (CKD-EPI-cr, MDRD, CKD-EPI-cys, CKD-EPI-cr-cys: p=0.0001, CG and CrCl: p=0.001) and A1 (for all GFRs p=0.0001) groups. CKD-EPI-cr (p=0.004), MDRD (p=0.01), CG (p=0.037), CKD-EPI-cys (p=0.033), and CKD-EPI-cr-cys (p=0.016) eGFRs in the A2 group were significantly different from the A1 group. All eGFRs showed a moderate correlation with CrCl in the A1group (CKD-EPI-cr and CKD-EPI-cr-cys: r=0.49, p=0.0001, MDRD: r=0.44, p=0.001, CG r=0.48, p=0.0001: CKD-EPI-cys r=0.40, p=0.004). The area under the CKD-EPI-cys ROC curve was the highest and found to be 0.847 (95%CI 0.763-0.931, p=0.0001). Conclusions: Our results showed that the CKD-EPI-cys eGFR can be useful in detecting the early stage of DN and more predictive than the others for prediction of DN.
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 43 (3) , 340-348
Open AccessAssessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
Introduction: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). Methods: Study group included 52 controls (46% male, age: 54.5±12.4) and 101 diabetic patients (46.5% male, age: 58.2±11). The diabetics were divided into three subgroups according to 24-hour urine albumin: normal to mildly increased (A1) (n=51), moderately increased (A2) (n=25), severely increased (A3) (n=25) albuminuria. Creatinine clearance (CrCl) was determined. Correlations between CrCl and eGFRs estimated according to the CKD-EPI, MDRD, and Cockcroft-Gault (CG) formulas, and ROC curves were evaluated. Data were analyzed using SPSS 22.0. Results: Only CKD-EPI-cys eGFR was significantly lower in the A1 group than the controls (p=0.021). All GFRs were lower in the A3 group than the control (CKD-EPI-cr, MDRD, CKD-EPI-cys, CKD-EPI-cr-cys: p=0.0001, CG and CrCl: p=0.001) and A1 (for all GFRs p=0.0001) groups. CKD-EPI-cr (p=0.004), MDRD (p=0.01), CG (p=0.037), CKD-EPI-cys (p=0.033), and CKD-EPI-cr-cys (p=0.016) eGFRs in the A2 group were significantly different from the A1 group. All eGFRs showed a moderate correlation with CrCl in the A1group (CKD-EPI-cr and CKD-EPI-cr-cys: r=0.49, p=0.0001, MDRD: r=0.44, p=0.001, CG r=0.48, p=0.0001: CKD-EPI-cys r=0.40, p=0.004). The area under the CKD-EPI-cys ROC curve was the highest and found to be 0.847 (95%CI 0.763-0.931, p=0.0001). Conclusions: Our results showed that the CKD-EPI-cys eGFR can be useful in detecting the early stage of DN and more predictive than the others for prediction of DN.